<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17</volume><submitter>Lei J</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Placental inflammation is a major contributor to preterm birth (PTB), and there are currently few targeted strategies to prevent PTB and its associated adverse neonatal outcomes. Serum amyloid A (SAA), particularly the isoforms SAA1 and SAA2, are well-recognized inflammatory markers, but their functional roles in placental inflammation remain poorly defined.&lt;h4>Methods&lt;/h4>Using a translational mouse model of sub-chronic maternal inflammation, we investigated the immune mechanisms and therapeutic potential of siRNA-mediated targeting of Saa2 (siSaa2). Placental expression patterns of SAA2 were examined &lt;i>in vivo&lt;/i>, and macrophage responses to extracellular SAA2 were modeled in vitro using RAW264.7 cells to assess downstream P2X7R-dependent signaling and functional o</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>1749966</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12855142</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Targeting SAA expression via siRNA mitigates preterm birth induced by maternal inflammation.</pubmed_title><pmcid>PMC12855142</pmcid><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Lei J</pubmed_authors><pubmed_authors>Liu A</pubmed_authors><pubmed_authors>Enninga EAL</pubmed_authors><pubmed_authors>Burd I</pubmed_authors><pubmed_authors>Townsel C</pubmed_authors><pubmed_authors>Jones-Beatty K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting SAA expression via siRNA mitigates preterm birth induced by maternal inflammation.</name><description>&lt;h4>Introduction&lt;/h4>Placental inflammation is a major contributor to preterm birth (PTB), and there are currently few targeted strategies to prevent PTB and its associated adverse neonatal outcomes. Serum amyloid A (SAA), particularly the isoforms SAA1 and SAA2, are well-recognized inflammatory markers, but their functional roles in placental inflammation remain poorly defined.&lt;h4>Methods&lt;/h4>Using a translational mouse model of sub-chronic maternal inflammation, we investigated the immune mechanisms and therapeutic potential of siRNA-mediated targeting of Saa2 (siSaa2). Placental expression patterns of SAA2 were examined &lt;i>in vivo&lt;/i>, and macrophage responses to extracellular SAA2 were modeled in vitro using RAW264.7 cells to assess downstream P2X7R-dependent signaling and functional o</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026</publication><modification>2026-06-19T04:56:48.543Z</modification><creation>2026-06-19T03:06:40.655Z</creation></dates><accession>S-EPMC12855142</accession><cross_references><pubmed>41624166</pubmed><doi>10.3389/fphar.2026.1749966</doi></cross_references></HashMap>